Clinical Trials Browser

Prostatic Neoplasms

Prostatic Neoplasms

Prostate Adenocarcinoma

Prostatic Neoplasms

Breast Neoplasms

Breast Cancer Invasive

Prostatic Neoplasms

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Breast Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Advanced Breast Cancer

Advanced Breast Cancer

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Anemia, Osteoporosis, Prostatic Neoplasms, Hot Flashes

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms, Male

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms, Recurrence

Breast Neoplasms, Primary Ovarian Insufficiency

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Hemorrhage, Leiomyoma

Breast Neoplasms

Clinical Trials

CASPAR

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

CARLHA-2

Detect V / CHEVENDO (Chemo vs. Endo)

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

URONCOR 06-24

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

SAFIA

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

ASPAIT

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

PATCH

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

COMPETE

MALE

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

POF

ELAAT

Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

ASTRRA